IndraLab

Statements


| 2

reach
"Dofetilide, bepridil, and cisapride are high or intermediate-proarrhythmic-risk drug that prolongs the QT by blocking hERG."

reach
"For example, bepridil appears not to interact with G648, Y652, or V659 and mutation of F656 and/or Y652 only slightly reduced hERG block by fluvoxamine and dronedarone."